Mahmoud Husseiny Awad

7PUBLICATIONS
10CO-AUTHORS
Ophthalmology and optometry not elsewhere classifiedGene and molecular therapyOptical technologyNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 18, 2026
Faricimab versus Aflibercept for Discharge and Readmission in Neovascular Age-Related Macular Degeneration: A Lesion-Type Stratified, Real-World UK Analysis.

|Jun 01, 2026
Challenging the Treatment Threshold: Early Faricimab Prevents Vision Loss in nAMD - A Real-World Welsh Experience.

|Apr 01, 2026
Real-World Outcomes of Switching to Faricimab in Treatment-Experienced and Resistant Neovascular Age-Related Macular Degeneration: A Single-Centre Retrospective Study.

Christopher Stewart, Jaskaran Singh Bhangu, Parinita Keshav Swarnkar

|Jan 16, 2026
Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel.

Richard Gale, Mahmoud Husseiny Awad, Clare Bailey

|Dec 22, 2025
Diabetic Eye Screening: Evaluation and Comparison of the Grading Results Between Community and Hospital Eye Services.

Christopher Stewart, Mokhalad Al-Duhaimi, Jaskaran Singh Bhangu

|Oct 14, 2024
Evaluating Faricimab in Treatment-Naive Neovascular Age Related Macular Degeneration: A Retrospective Analysis of Real-World Data.

Danielle Modeste, Christopher Stewart, Hajani Premanandhan

Pageof 2

Frequent Collaborators

5 joint publications

Christopher Stewart

3 joint publications

Jaskaran Singh Bhangu

2 joint publications

Parinita Keshav Swarnkar

2 joint publications

Mohammed Rifat